These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20390095)

  • 41. Preparation and In vitro Investigation of Chitosan Compressed Tablets for Colon Targeting.
    Bashardoust N; Jenita JL; Zakeri-Milani P
    Adv Pharm Bull; 2011; 1(2):87-92. PubMed ID: 24312762
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chitosan-chondroitin sulfate based matrix tablets for colon specific delivery of indomethacin.
    Amrutkar JR; Gattani SG
    AAPS PharmSciTech; 2009; 10(2):670-7. PubMed ID: 19459052
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An in situ crosslinked compression coat comprised of pectin and calcium chloride for colon-specific delivery of indomethacin.
    Wei X; Lu Y; Qi J; Wu B; Chen J; Xu H; Wu W
    Drug Deliv; 2015 May; 22(3):298-305. PubMed ID: 24471938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Release of indomethacin from bioadhesive tablets containing carbopol 941 modified with Abelmuschus esculentus (okra) gum.
    Attama AA; Adikwu MU; Amorha CJ
    Boll Chim Farm; 2003 Sep; 142(7):298-302. PubMed ID: 14677275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Colon-targeted delivery of solubilized bisacodyl by doubly enteric-coated multiple-unit tablet.
    Park HJ; Jung HJ; Ho MJ; Lee DR; Cho HR; Choi YS; Jun J; Son M; Kang MJ
    Eur J Pharm Sci; 2017 May; 102():172-179. PubMed ID: 28279763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and evaluation of dapsone tablets coated for specific colon release.
    Barros PD; Dias IFT; Zanin GD; Bunhak ÉJ
    Drug Dev Ind Pharm; 2020 Feb; 46(2):246-252. PubMed ID: 31951762
    [No Abstract]   [Full Text] [Related]  

  • 47. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biphasic drug release from film-coated tablets.
    Ofori-Kwakye K; Fell JT
    Int J Pharm; 2003 Jan; 250(2):431-40. PubMed ID: 12527169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation of Colon-Targeted Acetylharpagide Tablets and its Release Properties
    Liu D; Yan H; Kong Y; You Y; Li Y; Wang L; Tong Y; Wang J
    Front Pharmacol; 2018; 9():832. PubMed ID: 30154716
    [No Abstract]   [Full Text] [Related]  

  • 50. Novel microbially triggered colon specific delivery system of 5-Fluorouracil: statistical optimization, in vitro, in vivo, cytotoxic and stability assessment.
    Dev RK; Bali V; Pathak K
    Int J Pharm; 2011 Jun; 411(1-2):142-51. PubMed ID: 21463667
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro evaluation of calcium pectinate: a potential colon-specific drug delivery carrier.
    Rubinstein A; Radai R; Ezra M; Pathak S; Rokem JS
    Pharm Res; 1993 Feb; 10(2):258-63. PubMed ID: 8456074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral delayed-release system based on Zn-pectinate gel (ZPG) microparticles as an alternative carrier to calcium pectinate beads for colonic drug delivery.
    El-Gibaly I
    Int J Pharm; 2002 Jan; 232(1-2):199-211. PubMed ID: 11790504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Release of prednisolone and inulin from a new calcium-alginate chitosan-coated matrix system for colonic delivery.
    Araujo V; Gamboa A; Caro N; Abugoch L; Gotteland M; Valenzuela F; Merchant HA; Basit AW; Tapia C
    J Pharm Sci; 2013 Aug; 102(8):2748-59. PubMed ID: 23839971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery.
    Sinha VR; Mittal BR; Kumria R
    Int J Pharm; 2005 Jan; 289(1-2):79-85. PubMed ID: 15652201
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of an enteric coating formulation and process for tablets primarily composed of a highly water-soluble, organic acid.
    Crotts G; Sheth A; Twist J; Ghebre-Sellassie I
    Eur J Pharm Biopharm; 2001 Jan; 51(1):71-6. PubMed ID: 11154906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polysaccharides for colon targeted drug delivery.
    Chourasia MK; Jain SK
    Drug Deliv; 2004; 11(2):129-48. PubMed ID: 15200012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development and in-vitro evaluation of a colon-specific controlled release drug delivery system.
    Talukder RM; Fassihi R
    J Pharm Pharmacol; 2008 Oct; 60(10):1297-303. PubMed ID: 18812022
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Formulation and in-vitro evaluation of dextrin matrix tablet of Ibuprofen for colon specific drug delivery.
    Salunkhe KS; Kulkarni MV
    Pak J Pharm Sci; 2008 Jan; 21(1):17-20. PubMed ID: 18166513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.
    Khan MZ; Prebeg Z; Kurjaković N
    J Control Release; 1999 Mar; 58(2):215-22. PubMed ID: 10053194
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of enteric-coated timed-release matrix tablets for colon targeting.
    Alvarez-Fuentes J; Fernández-Arévalo M; González-Rodríguez ML; Cirri M; Mura P
    J Drug Target; 2004; 12(9-10):607-12. PubMed ID: 15621686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.